Open AccessOxyphenbutazone in Vaginal Operations for Genital Prolapse
Author(s) -
Bergsjø Per
Publication year - 1970
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.3109/00016347009158044
Subject(s) - oxyphenbutazone , medicine , placebo , surgery , sex organ , phenylbutazone , alternative medicine , pathology , biology , genetics
. The effects of oxyphenbutazone (Tanderil) during the first week following vaginal operations for prolapse have been studied by the double‐blind technique. The series comprised 84 patients, 41 of whom received the drug and 43 the placebo. A loading dose was given on the day before the operation, and the medications continued until the seventh post‐operative day. There was a statistically significant decrease in the use of analgesics, and a persistent but not significant lowering of the rectal temperature in the oxyphenbutazone group. The recovery of bladder function was equal in the two groups, as were the side effects and complications. Judged by the nurses' unbiased report of the post‐operative course, there was a tendency towards an uncomplicated course in the oxyphenbutazone‐treated as compared with the placebo‐treated patients.